Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-kinase/Akt/Raf-1 interaction: A potential therapeutic benefit for arthritis

Arthritis and Rheumatism

Volumn 58, Issue 10, 2008, Pages 3145-3156

  Lin, Sze Kwan ^a   Chang, Hao Hueng ^a   Chen, Yunn Jy ^a   Wang, Chih Chiang ^a   Galson, Deborah L ^b   Hong, Chi Yuan ^a,c   Kok, Sang Heng ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIGALLOCATECHIN GALLATE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAF PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C FOS; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; UPREGULATION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIOXIDANTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CATECHIN; CELLS, CULTURED; CHEMOKINE CCL2; DOWN-REGULATION; HUMANS; MALE; ONCOGENE PROTEIN V-AKT; OSTEOBLASTS; PROTO-ONCOGENE PROTEINS C-RAF; RATS; SIGNAL TRANSDUCTION;

EID: 54949101985     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23937     Document Type: Article

References (35)

1. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF [review]. Cytokine 1989;1:2-13.
2. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family [review]. Annu Rev Immunol 1991;9:617-48.
3. Rollins BJ. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease [review]. Mol Med Today 1996;2:198-204.
4. Lisignoli G, Toneguzzi S, Pozzi C, Piacentini A, Riccio M, Ferruzzi A, et al. Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1999;26:791-9.
5. Heymann D, Rousselle AV. gp130 cytokine family and bone cells [review]. Cytokine 2000;12:1455-68.
6. Langdon C, Leith J, Smith F, Richards CD. Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro. Arthritis Rheum 1997;40:2139-46.
7. Rowan AD, Hui W, Cawston TE, Richards CD. Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model. Am J Pathol 2003;162:1975-84.
8. Lin SK, Kok SH, Yeh FT, Kuo MY, Lin CC, Wang CC, et al. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor. Arthritis Rheum 2004;50:785-93.
9. Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids [review]. Crit Rev Food Sci Nutr 1997;37:693-704.
10. Chung JY, Park JO, Phyu H, Dong Z, Yang CS. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3′-digallate. FASEB J 2001;15:2022-4.
11. Pianetti S, Guo S, Kavanagh KT, Sonenshein GE. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res 2002;62:652-5.
12. Chung JH, Han JH, Hwang EJ, Seo JY, Cho KH, Kim KH, et al. Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. FASEB J 2003;17:1913-5.
13. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/ MEK/ERK pathway by protein interactions [review]. Biochem J 2000;351:289-305.
14. Zimmermann S, Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 1999;286:1741-4.
15. Tzivion G, Luo Z, Avruch J. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 1998;394:88-92.
16. Kubicek M, Pacher M, Abraham D, Podar K, Eulitz M, Baccarini M. Dephosphorylation of Ser-259 regulates Raf-1 membrane association. J Biol Chem 2002;277:7913-9.
17. Dhillon AS, Meikle S, Yazici Z, Eulitz M, Kolch W. Regulation of Raf-1 activation and signalling by dephosphorylation. EMBO J 2002;21:64-71.
18. Andjelkovic M, Maira SM, Cron P, Parker PJ, Hemmings BA. Domain swapping used to investigate the mechanism of protein kinase B regulation by 3-phosphoinositide-dependent protein kinase 1 and Ser473 kinase. Mol Cell Biol 1999;19:5061-72.
19. Ahmed S, Pakozdi A, Koch AE. Regulation of interleukin-1β-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2006;54:2393-401.
20. Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1β- induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther 2004;308:767-73.
21. Singh R, Ahmed S, Islam N, Goldberg VM, Haqqi TM. Epigallocatechin-3- gallate inhibits interleukin-1β-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor κB activation by degradation of the inhibitor of nuclear factor κB. Arthritis Rheum 2002;46:2079-86.
22. Haqqi TM, Anthony DD, Gupta S, Ahmad N, Lee MS, Kumar GK, et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A 1999;96:4524-9.
23. Tare RS, Oreffo RO, Clarke NM, Roach HI. Pleiotrophin/ osteoblast-stimulating factor 1: dissecting its diverse functions in bone formation. J Bone Miner Res 2002;17:2009-20.
24. Goodin MG, Rosengren RJ. Epigallocatechin gallate modulates CYP450 isoforms in the female Swiss-Webster mouse. Toxicol Sci 2003;76:262-70.
25. Wang Y, Kristan J, Hao L, Lenkoski CS, Shen Y, Matis LA. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J Immunol 2000;164:4340-7.
26. Zhan Y, Brown C, Maynard E, Anshelevich A, Ni W, Ho IC, et al. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 2005;115:2508-16.
27. Clerk A, Pham FH, Fuller SJ, Sahai E, Aktories K, Marais R, et al. Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1. Mol Cell Biol 2001;21:1173-84.
28. Scheid MP, Woodgett JR. Unravelling the activation mechanisms of protein kinase B/Akt [review]. FEBS Lett 2003;546:108-12.
29. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655-7.
30. Bigelow RL, Cardelli JA. The green tea catechins, (-)-epigallocatechin-3- gallate (EGCG) and (-)-epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene 2006;25:1922-30.
31. Sah JF, Balasubramanian S, Eckert RL, Rorke EA. Epigallocatechin-3- gallate inhibits epidermal growth factor receptor signaling pathway: evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 2004;279:12755-62.
32. Lorenz M, Wessler S, Follmann E, Michaelis W, Dusterhoft T, Baumann G, et al. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 2004;279:6190-5.
33. Legube G, Trouche D. Regulating histone acetyltransferases and deacetylases [review]. EMBO Rep 2003;4:944-7.
34. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression [review]. Annu Rev Biochem 2006;75:243-69.
35. Zika E, Ting JP. Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes. Curr Opin Immunol 2005;17:58-64.